BAP1 and malignant mesothelioma: BRCA1 associated-protein 1 (BAP1) tumor predisposition syndrome (BAP1–TPDS) is associated with the onset of cutaneous melanocytic tumors, malignant mesotheliomas, uveal and cutaneous melanomas, renal cell carcinomas, and potentially other internal malignancies [1–3].